为固体瘤推进细胞疗法:克服生物,操作和监管障碍的途径
Kedar Kirtane1, Michael Kalos2, Rocky Billups3
1Head & Neck-Endocrine Oncology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, USA.
Transplantation and cellular therapy
|February 28, 2026
概括
开发用于固体瘤的细胞疗法需要创新的策略来克服生物和操作方面的挑战. 一个协作框架强调标准化,区域制造和监管重新校准,以获得更广泛的患者访问.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法 细胞疗法
背景情况:
- 细胞疗法已经改变了血液性恶性瘤治疗.
- 新兴应用对固体瘤有希望,但面临着独特的挑战.
研究的目的:
- 提出一个框架,以推进细胞疗法在固体瘤的发展.
- 解决生物,运营,制造和监管方面的障碍.
主要方法:
- 在2025年关于推进固体瘤细胞治疗的峰会上获悉.
- 提出了一种合作运营模式,强调标准化和区域枢纽.
- 强调需要进行监管重新校准和付款人的参与.
主要成果:
- 确定了关键挑战:抗原异质性,毒性,免疫抑制和可访问性.
- 概述了策略:枢纽和分支网络,早期转诊和加强提供者培训.
- 倡导材料银行,数据驱动的监管方法和定制认证.
结论:
- 跨学科合作对于在固体瘤中获得公平和安全的细胞疗法至关重要.
- 运营和监管方面的创新对于可扩展性和质量保证至关重要.
- 细胞疗法具有超出血液性恶性瘤的潜力,需要战略性发展.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K


